These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12618256)

  • 41. Comparison of isosorbide mononitrate and misoprostol for cervical ripening in termination of pregnancy between 8 and 12 weeks: a randomized controlled trial.
    Duhan N; Gupta S; Dahiya K; Sirohiwal D; Rohilla S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1245-8. PubMed ID: 20549511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
    Singh K; Fong YF; Prasad RN; Dong F
    Hum Reprod; 1999 Jun; 14(6):1635-7. PubMed ID: 10357990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study.
    Ngai SW; Yeung KC; Lao T; Ho PC
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1120-3. PubMed ID: 8917000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of misoprostol for cervical ripening prior to pregnancy interruption before twelve weeks of gestation.
    Okanlomo KA; Ngotho D; Moodley J
    East Afr Med J; 1999 Oct; 76(10):552-5. PubMed ID: 10734504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming.
    Singh K; Fong YF; Prasad RN; Dong F
    Obstet Gynecol; 1998 Nov; 92(5):795-8. PubMed ID: 9794671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy.
    Aronsson A; Ulfgren AK; Ståbi B; Stavreus-Evers A; Gemzell-Danielsson K
    Contraception; 2005 Jul; 72(1):33-9. PubMed ID: 15964290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial.
    von Hertzen H; Piaggio G; Huong NT; Arustamyan K; Cabezas E; Gomez M; Khomassuridze A; Shah R; Mittal S; Nair R; Erdenetungalag R; Huong TM; Vy ND; Phuong NT; Tuyet HT; Peregoudov A;
    Lancet; 2007 Jun; 369(9577):1938-46. PubMed ID: 17560446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester abortions (12-16 weeks).
    Nucatola D; Saulsberry V; Gatter M; Roth N
    Contraception; 2009 Feb; 79(2):158. PubMed ID: 19135576
    [No Abstract]   [Full Text] [Related]  

  • 53. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate.
    Radulovic N; Norström A; Ekerhovd E
    Acta Obstet Gynecol Scand; 2007; 86(3):344-8. PubMed ID: 17364311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français.
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sublingual misoprostol for first trimester termination of pregnancy.
    Fekih M; Fathallah K; Ben Regaya L; Bouguizane S; Chaieb A; Bibi M; Khairi H
    Int J Gynaecol Obstet; 2010 Apr; 109(1):67-70. PubMed ID: 20053398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
    Tang OS; Xu J; Cheng L; Lee SW; Ho PC
    Hum Reprod; 2002 Jul; 17(7):1738-40. PubMed ID: 12093832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral versus vaginal misoprostol administered one hour before surgical termination of pregnancy: a randomised controlled trial.
    Sharma S; Refaey H; Stafford M; Purkayastha S; Parry M; Axby H
    BJOG; 2005 Apr; 112(4):456-60. PubMed ID: 15777444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervical ripening prior to hysteroscopy: is the application of misoprostol useful?
    Arena S; Zupi E; Affronti G
    Minerva Ginecol; 2011 Oct; 63(5):439-48. PubMed ID: 21926953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
    Oppegaard KS; Qvigstad E; Nesheim BI
    BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study using two dose regimens (200 microg or 400 microg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae.
    Fong YF; Singh K; Prasad RN
    Br J Obstet Gynaecol; 1998 Apr; 105(4):413-7. PubMed ID: 9609268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.